Cargando…

Effect of the pharmacist-managed cardiovascular risk reduction services on diabetic retinopathy outcome measures

BACKGROUND: Diabetic retinopathy (DR) is a progressive, sight-threatening long-term complication of diabetes. Diabetes disease management reduces the risk of developing or progression to a severe form of DR. However, there are no reports of the potential role of pharmacists in DR progression. OBJECT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weber, Zachary A., Kaur, Palakpreet, Hundal, Amrita, Ibriga, Somnooma H., Bhatwadekar, Ashay D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centro de Investigaciones y Publicaciones Farmaceuticas 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463412/ https://www.ncbi.nlm.nih.gov/pubmed/31015869 http://dx.doi.org/10.18549/PharmPract.2019.1.1319

Ejemplares similares

Senolytics in the treatment of diabetic retinopathy
por: Hassan, Jannah Waled, et al.
Publicado: (2022)

Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment
por: Leley, Sameer P, et al.
Publicado: (2021)

miR-92a and integrin expression in fibrovascular membranes in proliferative diabetic retinopathy
por: Luo, Qianyi, et al.
Publicado: (2023)

Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World
por: Bhatwadekar, Ashay D., et al.
Publicado: (2021)

Editorial: Cell-Based Therapies for Diabetic Microvascular Complications
por: Bhatwadekar, Ashay D.
Publicado: (2015)

Combining transfer learning with retinal lesion features for accurate detection of diabetic retinopathy
por: Hassan, Doaa, et al.
Publicado: (2022)

Diabetes Alters Diurnal Rhythm of Electroretinogram in db/db Mice
por: Di, Rong, et al.
Publicado: (2019)

Metformin Corrects Abnormal Circadian Rhythm and Kir4.1 Channels in Diabetes
por: Alex, Alpha, et al.
Publicado: (2020)

Circadian rhythm disruption results in visual dysfunction
por: Mathew, Deepa, et al.
Publicado: (2022)

Liver X Receptor Modulates Diabetic Retinopathy Outcome in a Mouse Model of Streptozotocin-Induced Diabetes
por: Hazra, Sugata, et al.
Publicado: (2012)

Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes
por: Luo, Qianyi, et al.
Publicado: (2022)

The Diurnal Rhythm of Insulin Receptor Substrate-1 (IRS-1) and Kir4.1 in Diabetes: Implications for a Clock Gene Bmal1
por: Luo, Qianyi, et al.
Publicado: (2019)

Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock
por: Busik, Julia V., et al.
Publicado: (2009)

Cardiovascular Disease, Neuropathy, and Retinopathy
por: Bloomgarden, Zachary T.
Publicado: (2009)

miR-92a Corrects CD34(+) Cell Dysfunction in Diabetes by Modulating Core Circadian Genes Involved in Progenitor Differentiation
por: Bhatwadekar, Ashay D., et al.
Publicado: (2015)

Community pharmacists’ routine provision of drug-related problem-reduction services
por: Al-Taani, Ghaith M., et al.
Publicado: (2022)

Pharmacist Services
por: Schommer, Jon C., et al.
Publicado: (2019)

Advanced glycation of the Arg-Gly-Asp (RGD) tripeptide motif modulates retinal microvascular endothelial cell dysfunction
por: McDonald, Denise M., et al.
Publicado: (2009)

Advanced glycation end (AGE) product modification of laminin downregulates Kir4.1 in retinal Müller cells
por: Thompson, Kayla, et al.
Publicado: (2018)

Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study
por: Parry, Rachel A., et al.
Publicado: (2021)

Pharmacist Provided Spirometry Services: A Scoping Review
por: Valentino, Alexa Sevin, et al.
Publicado: (2021)

Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
por: Vilsbøll, Tina, et al.
Publicado: (2018)

Physicians' views on cardiovascular disease risk prevention services by pharmacists and potential for collaboration
por: Almansour, Hadi A., et al.
Publicado: (2021)

Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases
por: Omboni, Stefano, et al.
Publicado: (2018)

Rationale for integration of services for diabetes mellitus and diabetic retinopathy in Kenya
por: Mwangi, Nyawira, et al.
Publicado: (2022)

Efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients, a randomized controlled trial - “Pharm-MD”: Impact of clinical pharmacists in diabetes care
por: Halalau, Alexandra, et al.
Publicado: (2022)

The intervention strategies and service model for pharmacist-led diabetes management: a scoping review
por: Hassan, Fahmi, et al.
Publicado: (2023)

Effectiveness of a Pharmacist-Led Cardiovascular Risk Reduction Clinic in Rural Perry County, Alabama
por: Murphy, Pilar Z., et al.
Publicado: (2016)

An integrated, mobile service for diabetic retinopathy in rural India
por: Sharma, Mohita, et al.
Publicado: (2011)

Situational analysis of diabetic retinopathy treatment Services in Ghana
por: Mensah-Debrah, Agatha, et al.
Publicado: (2021)

Per2-Mediated Vascular Dysfunction Is Caused by the Upregulation of the Connective Tissue Growth Factor (CTGF)
por: Jadhav, Vaishnavi, et al.
Publicado: (2016)

Diabetic retinopathy predicts cardiovascular mortality in diabetes: a meta-analysis
por: Xu, Xiao-Hong, et al.
Publicado: (2020)

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis
por: Thomas, R L, et al.
Publicado: (2012)

Dicer Expression Exhibits a Tissue-Specific Diurnal Pattern That Is Lost during Aging and in Diabetes
por: Yan, Yuanqing, et al.
Publicado: (2013)

Budget Impact Analysis of Pharmacist-Led Medication Management in Cardiovascular and Type 2 Diabetic Patients
por: Mucalo, Iva, et al.
Publicado: (2022)

Pharmacists’ and patients’ perceptions about the importance of pharmacist services types to improve medication adherence among patients with diabetes in Indonesia
por: Presley, Bobby, et al.
Publicado: (2021)

Planning diabetic retinopathy services — lessons from Latin America
por: von-Bischhoffshausen, Fernando Barráa, et al.
Publicado: (2011)

Third-party Reimbursement of Pharmacist-Led Cardiovascular and Diabetes Preventive Health Services for Workplace Health Initiatives: A Narrative Systematic Review
por: Tong, Brandon, et al.
Publicado: (2021)

Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy
por: Damkondwar, Deepali R, et al.
Publicado: (2012)

Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy
por: Vivekanandan, S
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_77hbghakl1nlpthg5pgt4aq08f